File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.jinf.2019.11.024
- Scopus: eid_2-s2.0-85078854195
- PMID: 31954742
- WOS: WOS:000516606700009
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Specificity, kinetics and longevity of antibody responses to avian influenza A(H7N9) virus infection in humans
Title | Specificity, kinetics and longevity of antibody responses to avian influenza A(H7N9) virus infection in humans |
---|---|
Authors | |
Keywords | Antibody response Clinical severity Follow-up Influenza A(H7N9) |
Issue Date | 2020 |
Publisher | WB Saunders Co Ltd. The Journal's web site is located at http://www.elsevier.com/locate/jinf |
Citation | Journal of Infection, 2020, v. 80 n. 3, p. 310-319 How to Cite? |
Abstract | Objectives: The long-term dynamics of antibody responses in patients with influenza A(H7N9) virus infection are not well understood. Methods: We conducted a longitudinal serological follow-up study in patients who were hospitalized with A(H7N9) virus infection, during 2013-2018. A(H7N9) virus-specific antibody responses were assessed by hemagglutination inhibition (HAI) and neutralization (NT) assays. A random intercept model was used to fit a curve to HAI antibody responses over time. HAI antibody responses were compared by clinical severity. Results: Of 67 patients with A(H7N9) virus infection, HAI antibody titers reached 40 on average 11 days after illness onset and peaked at a titer of 290 after three months, and average titers of ≥80 and ≥40 were present until 11 months and 22 months respectively. HAI antibody responses were significantly higher in patients who experienced severe disease, including respiratory failure and acute respiratory distress syndrome, compared with patients who experienced less severe illness. Conclusions: Patients with A(H7N9) virus infection who survived severe disease mounted higher antibody responses that persisted for longer periods compared with those that experienced moderate disease. Studies of convalescent plasma treatment for A(H7N9) patients should consider collection of donor plasma from survivors of severe disease between 1 and 11 months after illness onset. |
Persistent Identifier | http://hdl.handle.net/10722/304525 |
ISSN | 2023 Impact Factor: 14.3 2023 SCImago Journal Rankings: 2.669 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chen, J | - |
dc.contributor.author | Zhu, H | - |
dc.contributor.author | Horby, PW | - |
dc.contributor.author | Wang, Q | - |
dc.contributor.author | Zhou, J | - |
dc.contributor.author | Jiang, H | - |
dc.contributor.author | Liu, L | - |
dc.contributor.author | Zhang, T | - |
dc.contributor.author | Zhang, Y | - |
dc.contributor.author | Chen, X | - |
dc.contributor.author | Deng, X | - |
dc.contributor.author | Nikolay, B | - |
dc.contributor.author | Wang, W | - |
dc.contributor.author | Cauchemez, S | - |
dc.contributor.author | Guan, Y | - |
dc.contributor.author | Uyeki, TM | - |
dc.contributor.author | Yu, H | - |
dc.date.accessioned | 2021-09-23T09:01:16Z | - |
dc.date.available | 2021-09-23T09:01:16Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Journal of Infection, 2020, v. 80 n. 3, p. 310-319 | - |
dc.identifier.issn | 0163-4453 | - |
dc.identifier.uri | http://hdl.handle.net/10722/304525 | - |
dc.description.abstract | Objectives: The long-term dynamics of antibody responses in patients with influenza A(H7N9) virus infection are not well understood. Methods: We conducted a longitudinal serological follow-up study in patients who were hospitalized with A(H7N9) virus infection, during 2013-2018. A(H7N9) virus-specific antibody responses were assessed by hemagglutination inhibition (HAI) and neutralization (NT) assays. A random intercept model was used to fit a curve to HAI antibody responses over time. HAI antibody responses were compared by clinical severity. Results: Of 67 patients with A(H7N9) virus infection, HAI antibody titers reached 40 on average 11 days after illness onset and peaked at a titer of 290 after three months, and average titers of ≥80 and ≥40 were present until 11 months and 22 months respectively. HAI antibody responses were significantly higher in patients who experienced severe disease, including respiratory failure and acute respiratory distress syndrome, compared with patients who experienced less severe illness. Conclusions: Patients with A(H7N9) virus infection who survived severe disease mounted higher antibody responses that persisted for longer periods compared with those that experienced moderate disease. Studies of convalescent plasma treatment for A(H7N9) patients should consider collection of donor plasma from survivors of severe disease between 1 and 11 months after illness onset. | - |
dc.language | eng | - |
dc.publisher | WB Saunders Co Ltd. The Journal's web site is located at http://www.elsevier.com/locate/jinf | - |
dc.relation.ispartof | Journal of Infection | - |
dc.subject | Antibody response | - |
dc.subject | Clinical severity | - |
dc.subject | Follow-up | - |
dc.subject | Influenza A(H7N9) | - |
dc.title | Specificity, kinetics and longevity of antibody responses to avian influenza A(H7N9) virus infection in humans | - |
dc.type | Article | - |
dc.identifier.email | Zhu, H: zhuhch@hku.hk | - |
dc.identifier.email | Guan, Y: yguan@hkucc.hku.hk | - |
dc.identifier.authority | Zhu, H=rp01535 | - |
dc.identifier.authority | Guan, Y=rp00397 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1016/j.jinf.2019.11.024 | - |
dc.identifier.pmid | 31954742 | - |
dc.identifier.pmcid | PMC7112568 | - |
dc.identifier.scopus | eid_2-s2.0-85078854195 | - |
dc.identifier.hkuros | 325462 | - |
dc.identifier.volume | 80 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 310 | - |
dc.identifier.epage | 319 | - |
dc.identifier.isi | WOS:000516606700009 | - |
dc.publisher.place | United Kingdom | - |